Press Release
Back arrow blue Back

The Center for Cancer and Blood Disorders Selects Flatiron Health OncoEMR to Support Its Transition to Value-Based Care

NEW YORK, NY, May 18, 2016Flatiron Health announced today that The Center for Cancer and Blood Disorders, a comprehensive community oncology practice with nine locations in the Fort Worth, Texas region, selected OncoEMR® as their medical oncology electronic health record solution to support long-term value-based care initiatives and meet the practice’s evolving technology needs.

“As one of the only remaining large, independent oncology practice's in the Fort Worth area, we strive to stay on the cutting edge of oncology so we can provide our patients with the high quality, integrated care they deserve while meeting the new value-based care reporting requirements,” said Barry Russo, chief executive officer, The Center for Cancer and Blood Disorders. “Flatiron Health has the engineering expertise to innovate and adapt quickly with us, plus a level of oncology background that we have yet to see in other software companies.”

OncoEMR is one of the most advanced cloud-based electronic health records (EHR) currently available for medical oncology. First launched in 2004, OncoEMR is designed by a leading engineering and clinical team that regularly innovates to deliver the most sophisticated point of care tools. In addition, OncoEMR automates key value-based care reporting requirements to support efficient and successful participation in alternative payment models like the Oncology Care Model.

“By utilizing OncoEMR, we will now have access to all patient information in one place, which not only enhances clinical decision-making but also the quality of care we can provide to our patients,” said Ray Page, DO, PhD, The Center for Cancer and Blood Disorders. “Additionally, OncoEMR is the best choice for us because it’s an innovative, medical oncology focused solution that will soon be interoperable with our radiation oncology software to streamline operational efficiencies.”

OncoEMR is a key product of the Flatiron Health OncologyCloud® software suite for cancer clinics. The suite also includes OncoAnalytics®, a first-of-its-kind analytics tool that unlocks data from multiple systems. The Center for Cancer and Blood Disorders currently leverages OncoAnalytics to view actionable business and clinical intelligence. Together, Flatiron’s integrated OncoAnalytics and OncoEMR solution will enable CCBD to access deeper insights and identify further opportunities to enhance the quality and value of care they provide to their patients.

###

About Flatiron Health, Inc.

Flatiron Health helps the oncology community deliver better, more efficient care by powering an innovative platform to address today’s healthcare challenges. The Flatiron Health OncologyCloud™ platform includes the industry-leading electronic medical record for oncology, advanced analytics, patient portal, and integrated billing management. Backed by Google Ventures, First Round Capital, Roche and others, Flatiron's industry-first technology platform and integrated suite of products deliver comprehensive support for cancer care providers and life science companies. For more information, please visit www.flatiron.com.